[go: up one dir, main page]

WO2013064885A1 - Procédé de détection et/ou d'isolement d'une biomolécule faisant appel à des nanostructures - Google Patents

Procédé de détection et/ou d'isolement d'une biomolécule faisant appel à des nanostructures Download PDF

Info

Publication number
WO2013064885A1
WO2013064885A1 PCT/IB2012/002200 IB2012002200W WO2013064885A1 WO 2013064885 A1 WO2013064885 A1 WO 2013064885A1 IB 2012002200 W IB2012002200 W IB 2012002200W WO 2013064885 A1 WO2013064885 A1 WO 2013064885A1
Authority
WO
WIPO (PCT)
Prior art keywords
nanostructure
biomolecule
group
linker
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2012/002200
Other languages
English (en)
Inventor
Arockiadoss THEVASAHAYAM
Harsh VARDHAN
Kiran R. AATRE
Debiprosad ROY MAHAPATRA
Chandrasekhar Bhaskaran Nair
Leela Mana OLAPPAMANA
Manoj Narayanan MULAKKAPURATH
Shilpa Sanjeeva KAMMARADI
Madhusmitaa MISHRA
Manish PRIYADARSHI
Anil Krishna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bigtec Pvt Ltd
Original Assignee
Bigtec Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bigtec Pvt Ltd filed Critical Bigtec Pvt Ltd
Publication of WO2013064885A1 publication Critical patent/WO2013064885A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Definitions

  • the present invention relates to a method for detection and/or isolation of biomolecule using composition comprising a composite comprising nanostructures attached with a photolytic material via a linker.
  • a biosensor is an analytical device that incorporates a biological recognition element in direct spatial contact with a transduction element.
  • Molecular recognition and signal transduction are the two major challenges in biosensor design.
  • Current biological sensing techniques commonly rely on optical detection principles. The earliest techniques involving optical detection were perceived to be inherently complex and also required multiples steps between the actual engagement of the analyte and the generation of a signal. The techniques usually also involve multiple reagents, preparative steps, signal amplification, complex data analysis and/or relatively large sample size.
  • Nanotechnology is emerging as a major discipline that is driving applications in a broad spectrum of fields and is making its presence felt in electronics, optical devices, industries, diagnostics, drug delivery, biosensing, imaging, as well as a variety of consumer products.
  • the technology uses highly innovative approaches through diverse strategies and architectures for overcoming the challenges of the conventional optical, • biochemical and biophysical methods.
  • One-dimensional nanostructured materials such as nanowires, nanotubes and nanorods by virtue of their small size, high sensitivity attributed to high surface-to-volume ratio, real time detection, ultra-low power demands, large surface area, near one-dimensionality of electronic transport, and potential for high-throughput and multiplexed detection are promising candidates for electronic detection of chemical and biological species.
  • Nanostructure is an article having at least one spatial dimension of less than 1 micron.
  • Nanostructured material also offer other significant advantages, such as new sensing mechanisms, high spatial resolution for localized detection, facile integration with standard wafer-scale semiconductor processing and label-free detection in a nondestructive manner. The technology can therefore be used for selective molecular recognition and isolation of biomolecules.
  • nanostructures include nanocages, nanocrystallites, nanobelts, nanoneedles, nanocomposites, nanofabrics, nanofibers, nanoflakes, nanoflowers, nanofoams, nanomeshes, nanoparticles, nanopillars, nanopin films, nanorings, nanorods, nanoshells, nanopowders, nanoclusters, nanowires, nanotubes, quantum dots, and quantum heterostructures.
  • 1 D-NS based detection systems There are mainly two sensing methodologies that are relevant to 1 D-NS based detection systems, namely electrical and optical. Electrical methods rely on the use of an electrical measurement as a sensor signal. A simple electrical is a resistor and a sensor that uses resistance as the sensor signal is often termed a chemiresistor. Due to the improved surface-to-volume ratio of 1 D-NS elements, this configuration is highly suited for the realization of biosensors. Other similar methods include the measurement of capacitance or impedance of the device and employing affinity based detection. Optical methodologies utilize the 1 D-NS as a marker (such as carbon nanotubes) or as a system (such as nanochannels). Typically, zero-dimensional nanostructures such as quantum dots are used as labels in bioanalytical applications.
  • Certain types of nanostructures that have found increasing incorporation into technologies include carbon-based nanostructures, such as carbon nanotubes and fullerenes; metal-based nanostructures, such as gold nanoparticles; and metal oxide- based nanostructures, such as Zinc oxide nanostructures and Titanium Oxide nanostructures.
  • ZnO nanostructured oxides have received ever increasing attention due to their interesting properties and unique applications in novel nanodevices.
  • zinc oxide (ZnO) nanostructures due to their stable and cost effective nature have found promising applications.
  • US201 1/0257033 describes a composition comprising a photoluminiscent nanostructure with a polymer adsorbed on the surface of the nanostructure for selective molecular recognition.
  • the polymer may be a polysaccharide or polynucleotide.
  • US2004/0132070 describes a nanotube based electronic detection device for detection of protein-protein binding.
  • the nanotube structure has a coating of electron donating polymer on the surface and has a receptor compound bound to the polymer.
  • Niepelt et al. (Raphael Niepelt, Ulrich C Schroder, Jana Sommerfeld, Irma Slowik, Beltina Rudolph, Robert Moller, Barbara Seise, Andrea Csaki, Wolfgang Fritzsche and Carsten Ronning. Biofunctionalization of zinc oxide nanowires for DNA sensory applications, Nanoscale Research Letters, 201 1 , 6:51 1 ) describes biofunctionalization of zinc oxide (ZnO) nanowires for the attachment of DNA target molecules on the nanowire surface. With the organosilane glycidyloxypropyltrimethoxysilane acting as a bifunctional linker, amino-modified capture molecule oligonucleotides were immobilized on the nanowire surface.
  • nanostructure compositions are available in the art for selective molecular detection of both chemical and biological molecules incorporating either electrical or optical sensing methodology.
  • the methods and devices disclosed herein enable easy and less time consuming detection as. well as isolation of the biomolecule using the embodiments disclosed in the application.
  • the nanostructures are biocompatible and exhibit a high degree of sensitivity for detection and/or isolation of a biomolecule.
  • An aspect of the present invention relates to a method for detecting and/or isolating a biomolecule of interest in a sample, wherein said method comprises contacting a sample comprising a biomolecule with a composite comprising a nanostructure attached with a photolytic material via a linker; detecting presence of composite-biomolecule complex formed, and isolating biomolecule from said composite-biomolecule complex.
  • Another aspect of the present invention relates to a composition for detecting a biomolecule of interest in a sample, wherein the composition comprises a plurality of nanostructures attached with a photolytic material via a linker.
  • Yet another aspect of the present invention relates to a device comprising a plurality of nanostructures attached with a photolytic material via a linker, a support and a substrate.
  • Figure 1 shows scanning electron microscopy image of ZnO nanorods grown on Zinc thin film by hydrothermal growth with a solution containing H 2 0 2 of 0.6 M concentration at a hydrothermal chamber pressure of 331 .15 MPa.
  • Figure 2 shows schematic diagram showing the hydrothermal setup for ZnO nanorod growth.
  • Figure 3 shows schematic diagram showing Growth shape of hexagonal ZnO nanorods.
  • Figure 4 shows schematic diagram showing the wurtzite structure of ZnO.
  • FIG. 5 shows Scanning Electron Microscopic (SEM) images of the grown nanorods with different surface to volume ratio conditions.
  • FIG. 6 shows a chemical structure of ZnO-EDC-PPP-DNA complex, in accordance with an implementation of the present subject matter, wherein A represents Zinc Oxide (ZnO), B represents l -ethyl-3-(3-dimethylaminopropyI) (EDC), C represents Protoporphyrin (PPP) and D represents DNA.
  • ZnO Zinc Oxide
  • EDC l -ethyl-3-(3-dimethylaminopropyI)
  • PPP Protoporphyrin
  • Figure 7 shows FTIR spectra of ZnO nanorods modification process: spectra marked Step (1 ) inidicates ZnO nanorod absorbance peaks. The results confirm successful functionalization of ZnO nanorods toward DNA binding.
  • Figure 8 shows Graph representing the UV spectrophotometric analysis of different concentration of ZnO nanorods used in functionalization.
  • Figure 9 shows Graph representing the optimization of time for enhanced functionalization of ZnO nanorods at a concentration of 2mg/ml.
  • Figure 10 shows FTIR spectra of ZnO nanorods modification process: (a) step ( 1 ) (bottom, black line), functionalized ZnO nanorods (b) step (2) PPP (3C ⁇ g) bound to functionalized nanorods (red line), (c) Step (3) immobilization of ssDNA ( ⁇ ⁇ ) on the functionalized nanorod (fZnO-PPP) (blue line).
  • Figure 1 1 shows Graph representing the UV-Vis spectrophotometric analysis of different concentration of PPP used in binding to functionalized ZnO nanorods.
  • the peak demarcated between dashed lines represents the one for protoporphyrin (PPP). Results confirm successful binding of PPP for increasing concentrations.
  • Figure 12 shows FTIR spectra of ZnO nanorods modification process: (a) step (1 ) (bottom, black line), PDHA bound to ZnO nanorods (b) step (2) PPP bound to DNA (red line), (c) Step (3) immobilization with ssDNA (blue line). Absorbance peak in step (3 ) confirm successful binding of DNA on functionalized ZnO nanorods.
  • Figure 13 shows The UV-spectrophotometric analysis demonstrating the DNA binding to f-ZnO-PPP followed by photocleavage of ZnO-PPP-DNA complex exposed to LED (wavelength 625 run) for 2 minutes. The extent of binding was checked with 3( ⁇ g/ml of PPP and different concentration of DNA i.e.
  • Figure 14 shows The Scanning Electron Micrograph depicting the ZnO nanorods anchored on the matrix of a nano composite polymer.
  • peptide refers to two or more amino acids joined to each other by peptide bonds or modified peptide bonds.
  • Peptides include those modified either by natural processes, such as processing and other post-translational modifications, but also chemical modification techniques. The modifications can occur anywhere in a peptide, including the peptide backbone, the amino acid side chain, and the amino or carboxyl terminal. Examples of modifications include but are not limited to amidation, acylation, acetylation, cross linking, cyclization, glycosylation, hydroxylation, phosphorylation, racemization, and covalent attachment of various moieties such as nucleotide or nucleotide derivative, lipid or lipid derivatives.
  • peptide and “polypeptide” can be used interchangeably.
  • amino acid will refer to the basic chemical structural unit of a protein or polypeptide.
  • fusion protein refers to a protein having at least two polypeptides covalently linked in which one polypeptide comes from one protein sequence or domain and the other polypeptide comes from a second protein sequence or domain.
  • a “gene” refers to a nucleic acid molecule whose nucleotide sequence codes for a polypeptide molecule. Genes may be uninterrupted sequences of nucleotides or they may include such intervening segments as introns, promoter regions, splicing sites and repetitive sequences.
  • a gene can be either RNA or DNA.
  • the R A or DNA can be single stranded or double stranded.
  • “Native gene” refers to a gene as found in nature with its own regulatory sequences.
  • Chimeric gene refers to any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature.
  • Synthetic genes can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form gene segments which are then enzymatically assembled to construct the entire gene.
  • “Chemically synthesized”, as related to a, sequence of DNA means that the component nucleotides were assembled in-vitro. Manual chemical synthesis of DNA may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines.
  • nanotube refers to a hollow article having a narrow dimension (width) of about 1 to 200 nm and a long dimension (length), where the ratio of the long dimension to the narrow dimension, i.e., the aspect ratio, is at least 5. In general, the aspect ratio is between 10 and 2000.
  • nanostructure means tubes, rods, cylinders, needles, spheres, particles, pillars, bundles, wafers, disks, sheets, plates, planes, cones, slivers, granules, ellipsoids, wedges, polymeric fibers, natural fibers, and other such objects, which have at least one spatial dimension less than about 100 nm.
  • Biomolecule as used herein is a chemical compound that naturally occurs in living organism. Biomolecules consists primarily of carbon and hydrogen, along with nitrogen, oxygen, phosphorous and sulphur. Other elements sometimes are incorporated but are much less common.
  • the present invention provides a method for isolation of biomolecules using nanostructure.
  • the nanostructures of the present invention can be carbon-based nanostructures, metal-based nanostructures or metal oxide-based nanostructures.
  • carbon based nanostructure examples include, but are not limited to carbon nanotubes and fullerenes.
  • metal based nanostructures include, but are not limited to Gold nanorods, Gold nanoparticles, Microgold, Gold nanowires, Gold nanospheres. Gold nanotubes.
  • metal oxides include, but are not limited to ZnO nanowires, ZnO nanotubes, ZnO nanopowder, ZnO nanorods, ZnO nanoneedles, ZnO nanospheres, ZnO nanoparticles, ZnO nanopillars, TiO nanowires, TiO nanotubes, TiO nanopowder, TiO nanorods, TiO nanoneedles, TiO nanospheres, TiO nanoparticles, TiO nanopillars and like.
  • nanostructures can be prepared using the conventional processes known in the art for example hydrothermal method, Sol-gel method, Vapor Transport method, electrodeposition and polymer assisted growth.
  • Chromatography is the separation technique of different biomolecules based on different sizes for a mobile versus a stationary phase.
  • the stationary phase through which mobile phase (liquid or gas) will flow, contains spherical particles packed into a column.
  • separation takes place because the sample proteins that have a greater attraction towards the solid phase move more slowly than the sample proteins are more attracted to the mobile phase.
  • Electrophoresis in biology use porous gels as the media.
  • the sample mixture is loaded into a gel, the electric field is applied, and the molecules migrate through the gel matrix.
  • separation is based on both the molecular sieve effect and on the electrophoretic mobility of the molecules. This method determines the size of biomolecules. It is used to separate proteins, and especially to separate DNA for identification, sequencing, or further manipulation.
  • the present invention discloses a method of detection, isolation, purification and/or concentrating or isolating target analytes from a biological sample for example blood, sputum, urine, stool, tissue, plasma marrow etc using a combination of nanomaterials, and surfaces and photolabile compounds.
  • the nanostructures and surfaces in fluidic channels are bound to photolabile compounds that are in turn bound to the specific target bioanalytes of interest that may be present in the biological matrix.
  • a light source is used to cleave the photolabile compound thereby releasing the target analyte into a solution that can be used for further analysis.
  • ZnO nanorods were used as the matrix and were functionalized with a bifunctional carboxylic acid, 16-(2-pyridyldithiol) hexadecanoic acid (PDHA) to facilitate binding with single stranded DNA (ssDNA) which can act as probe to detect complimentary DNA from target organisms.
  • This bifunctional acids binds to ZnO nanorods through carboxylic (COOH) functional group on one terminus and the other terminus binds to NH 2 modified ss DNA by substitution of succinimide end group (Taratula et a/.2009).
  • This ssONA functionalized ZnO nanostructures can hybridize with complimentary DNA extracted from targeted source such as diseased organisms.
  • nanostructures used in the composition for isolation and /or detection of a biomolecule as disclosed in the present invention does not show any gcnotoxic, cytotoxic and/or damaging side effects of the nanostructure to the biomolecule.
  • the linker used in the method of the present invention forms a layer around the nanostructure, which does not allow the biomolecule to come in direct contact with the nanostructure. This barrier created by the presence of the liker between the nanostructure and the biomolecule enables circumventing the genotoxic, cytotoxic and damaging effects of the nanostructure to the biomolecule.
  • the biomolecule in tum bind to the photolytic material which also makes its isolation easy and less time consuming.
  • the biomolecules obtained are in a substantially pure form and hence can directly be used for a variety of purposes, for example in biosensors or as biological markers, without the incorporation of a further purification step.
  • the cleavage of photocleavable markers are dependent on various factors, such as photo- linker or photo-reactive moiety, wavelength of the electromagnetic excitation, and geometrical arrangement of the compositions on a binding surface.
  • the present invention solves these problems associated with each of these aspects.
  • the recovery of post-photolysis yield without side effect is degraded due to production of side products.
  • UV-Vis spectroscopy shows only the peaks due to DNA and the elemental compositions of the composite comprising of ZnO peak, PPP peaks and no other peaks indicating that no other side products are formed.
  • IR light source is used for photo-cleaving in the present invention as opposed to UV light source used in reported photo-cleavage based bimolecular detection which may degrade protein and other biomolecules.
  • a certain distance (within about 10cm) of illumination is required according to reported literature and patents for photolytic-cleavage based biomolecular detection.
  • the light exposure distance has been minimized to less than 5cm.
  • This improvement in exposure distance is useful in compact arrangement of the detection scheme in a device.
  • This improvement in reduced exposure distance, reduced time of illumination and low concentration of photo-lytic molecules (PPP) is also possible optimize further due to spatial arrangement of the nanostructure on supporting platform in the form of a fluidic channels in two-dimensional and three-dimensional arrays.
  • the conventional DNA detection method based on DNA (PCR) and antibody selectivity significantly exploits the sequence specificity of the biomolecule. The sensitivity of such detection method demands purified biomolecules.
  • the DNA extraction and purification are based on chemical, thermal and other time consuming steps followed by chromatography and other methods for purified samples.
  • the overall detection time leads to several hours.
  • these methods have limited potential in field deployment, cost-effective and rapid consumption for assay.
  • the nanostructure based detection and/or assay system as disclosed in the present invention is capable of selective and sensitive detection of target biomolecules from a heterogenous source.
  • the cell lysate need not be processed by extensive purification steps for downstream detection.
  • the lysate achieved from electrical lysis of cells can be incubated with the nanostructure based linker for a time period of 1 minute for DNA binding and 2 minutes for photo-cleavage based detection.
  • a low concentration of 0.5 ⁇ DNA is found to be threshold for the detection.
  • the significance of the present invention lies in fast assay technique, simple and selective process as compared to the prior art.
  • the present invention is based on selective biomolecule binding to the nanostructure- support followed by photocleavge at the photolinker biomolecule bond. As specified in example 6, the DNA binding was achieved within 1 minute and binding stability was observed upto several minutes within 2 minutes leading to high detection sensitivity.
  • biomolecule detection is based on size based differentiation.
  • films with specific pore size were applied for separation, detection and quantification of biomolecules.
  • the process has several disadvantages like leakage through pores, non uniformity in pore dimensions and dependence on biomolecule diffusion kinetics for flow through pores.
  • the electrode based films for biomolecule affinity were limited by their strong dependence on electrode stability, conjugation chemistry and film fabrication.
  • the present invention overcomes the above drawbacks by simplified and stable fabrication process of nanostructures with linkers.
  • the nanostructure-linker complex as disclosed in the present invention acts as a bed downstream to cell lysis process where a heterogeneous system of biomolecules are formed in which the target biomolecules (e.g., DNA or protein) are mixed.
  • the DNA binding and cleavage would be detected by the photolinker-biomolecule conjugation and photolytic cleavage of the bond.
  • Post cleavage the qualitative and quantitative assay can be followed by simplified process of UV spectrophotometry, fluorimetry, gel analysis, microscopy and others.
  • crystalline ZnO nanorods are prepared by hydrothermal method with controlled condition of pressure, temperature and catalysts. The size, length and purity level along with morphology of the ZnO nanorod growth are optimized. The nanorods are grown on a seed layer or a substrate. The nanorods are then removed from the substrate or the seed layer for their functional ization.
  • the nanostructures are taken in powder form.
  • 2mM 16-(2-pyridyl dithiol) hexadecanoic acid (PDHA) taken in a mixture of ethanol and butanol in the ratio of 2: 1 along with N-(15-carboxy pentadecanoyloxy) succinimide (NHS).
  • PDHA 2-pyridyl dithiol hexadecanoic acid
  • NHS N-(15-carboxy pentadecanoyloxy) succinimide
  • the solution is mixed with the powdered ZnO nanostructure in Phosphate Buffer for upto 2 hours. Subsequently the mixture was washed with deionized water and dried.
  • functionalized nanostructures designated as "f- nanostructures” were are collected in powder form. The f- nanostructures were then attached to a linker.
  • linker includes, but are not limited to l -ethyl-3-(3- dimethylaminopropyl) (EDC), thio self assembly mono layer ( 1 ,8-octanedithiol); ( 1 ,4- bis(mercaptomethyl) benzene; l ,4-bis(mercaptomethyl) cyclohexane; 1 ,4- bis(mercaptoacetamido) benzene; l ,4-bis(mercaptoacetamido) cyclohexane and sulfhydryl.
  • EDC l -ethyl-3-(3- dimethylaminopropyl)
  • thio self assembly mono layer 1 ,8-octanedithiol
  • 1 ,4- bis(mercaptomethyl) benzene l ,4-bis(mercaptomethyl) cyclohexane
  • the functionalized nanostructures in powder form were mixed with a solution of N-(15-carboxy pentadecanoyloxy) succinimide (NHS) and 2-(N- morpholine)-ethane sulfonic acid (MES) in deionized water. After 5 minutes, the linker, l -ethyl-3-(3-dimethylaminopropyl) (EDC) was added and the final mixture was mixed for about 6 hours. The mixture was washed with deionized water and dried to collect nanostructure-linker in white powder form. The nanostructure-linker was attached to a photolytic material.
  • NHS N-(15-carboxy pentadecanoyloxy) succinimide
  • MES 2-(N- morpholine)-ethane sulfonic acid
  • EDC l -ethyl-3-(3-dimethylaminopropyl)
  • photolytic material examples include, but are not limited to Protoporphyrin (PPP), Porphyrin meso-tetrakis-[4-(carboxy methyleneoxy) phenyl] porphyrin (H2T4CPP), 6-hydroxy - l -methylene-3-oxo-3Hbenzopyrans, 6-methoxy - 1 -methylene- 3-oxo-3Hbenzopyrans, Aspartyl ⁇ -nitrobenzyl ester, chlorine peroxide molecule, 2- nitrobenzyl group, tetracationic monointercalant, cyclo-bisintercalant, 4,4-bipyridinium, oligonucleotides, oxazole yellow (YO), dimer of oxazole yellow (YOYO), dimer of thiazole orange (TOTO), cis- and trans- components.
  • PPP Protoporphyrin
  • H2T4CPP Porphyrin meso-tetrakis-
  • nanostructure-linker for attachment of photolytic material, nanostructure-linker was mixed with a solution containing N-(15-carboxy pentadecanoyloxy) succinimide (NHS), (2-(N-morpholine)-ethane sulfonic acid (MES) in deionized water.
  • NHS N-(15-carboxy pentadecanoyloxy) succinimide
  • MES (2-(N-morpholine)-ethane sulfonic acid
  • PPP was added and the entire mixture was dissolved in Methanol.
  • the solution mixture was stirred for about 6 hours in absence of light. Subsequently, the solution mixture was washed with deionized water and dried to collect nanostructure-linker-photolytic material complex (f- nanostructure-EDC-PPP) in the form of brown powder.
  • biomolecules are bound to the complex by contacting the complex with a sample comprising the biomolecule.
  • sample include, but are not limited to a crude extract, blood, semen, saliva, urine, mucus, stool, sputum, protein mixture and any other biological sample.
  • biomolecules include, but are not limited to amino acids, peptides and nucleic acid.
  • the peptides include polypeptides, proteins, fusion proteins and like.
  • the nucleic acid includes DNA or RNA.
  • the DNA and RNA may be single stranded or double stranded.
  • the DNA includes native genes, chimeric genes, foreign genes, synthetic genes and chemically synthesized gene.
  • the nanostructure-linker-photolytic material complex was mi xed with NHS, (2 -(N- morpholine)-ethane sulfonic acid (MES) in deionized water to obtain mixture.
  • the biomolecule sample was added to the mixture to obtain the nanostructure-linker- photolytic material-biomolecule complex.
  • Binding reaction time was optimized in the range of 30 seconds to 2 minutes depending on various parameters such as the size of the biomolecule and chemistry of end terminals.
  • the binding of biomolecules to the complex was confirmed by the conventional methods such as microscopy, Polymerase Chain Reaction (PCR), absorbance and scattering method.
  • the bound biomolecules were cleaved by exciting the solution containing the nanostructure-linker-photolytic material-biomolecule complex with light of suitable wavelength.
  • the wavelength is pre-selected depending on the absorption characteristics of the photolytic material used.
  • the light used can be a visible light or ultraviolet radiation or infrared radiation.
  • the present invention provides a method of detection of biomolecule that involves steps to overcome the toxicity effect of nanorods in the downstream screening process of biomolecules.
  • the ZnO nanorods of the present invention were synthesized by hydrothermal effect as described in Example 1 and thereafter embedded in a polymer of nanocomposite so as to firmly anchor the nanorods and prevent leaching into the medium.
  • This embodiment within the polymer yields a typical floral type of geometrical arrangement (Fig.14.) which exposes the nanorod tips for the step wise functionalization and binding of biomolecule. This process excludes the possibility of nanorod release into the test sample and its interfering effects in the diagnostic process.
  • the method of the present invention can further be used for extracting biomolecules, protein sizing and quantification, protein biomarker identification, drug discovery and disease screening.
  • Porphyrin-peptide conjugates are reported to be used in peptide as well as porphyrin delivery into cell (Mezo et al , 201 1 ).
  • synthetic oligopeptides can be conjugated to porphyrin molecules based on their metal cofactors and end terminal chemical bond.
  • the ZnO backbone as disclosed in the present invention can be linked to metalloporphyrins which can selectively bind to cationic aminoacids on a peptide chain.
  • the present invention in particular provides a method for isolation of biomolecules from a sample, the method comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule, wherein the nanostructure is selected from the group consisting of carbon nanotubes, fullerenes, Gold nanorods, Gold nanoparticles, Microgold, Gold nanovvires, Gold nanospheres, Gold nanotubes, Zinc oxide nanowires, Zinc oxide nanotubes, Zinc oxide nanopowder.
  • Zinc oxide nanorods Zinc oxide nanoneedles, Zinc oxide nanospheres, Zinc oxide nanoparticles , Zinc oxide nanopillars. Titanium oxide nanowires, Titanium oxide nanotubes, Titanium oxide nanopowder, Titanium oxide nanorods, Titanium oxide nanoneedles, Titanium oxide nanospheres, Titanium oxice nanoparticles, Titanium oxide nanopillars.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the nanostructure is Zinc oxide nanorods.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-Iinker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule, wherein the linker is selected from the group consisting of 1 - ethyl-3-(3-dimethylaminopropyl) (EDC), thio self assembly mono layer ( 1 ,8- octanedithiol); ( l ,4-bis(mercaptomethyl)benzene; l ,4-bis(mercaptomethyl)cyclohexane; l ,4-bis(mercaptoacetamido)benzene; 1 ,4-bis(mercaptoacet
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the linker is l -ethyl-3- (3-dimethylaminopropyl) (EDC).
  • EDC l -ethyl-3- (3-dimethylaminopropyl)
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the photolytic material is selected from the group consisting of Protoporphyrin (PPP), Porphyrin meso-tetrakis- [4-(carboxy methyleneoxy) phenyl] porphyrin (H2T4CPP), 6-hydroxy - l -methylene-3- oxo-3Hbenzopyrans, 6-methoxy - l -methylene-3-oxo-3Hbenzopyrans, Aspartyl ⁇ - nitrobenzyl ester, chlorine peroxide molecule,
  • PPP Protoporphyrin
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule, wherein the photolytic material is Protoporphyrin (PPP).
  • PPP Protoporphyrin
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the sample is selected from the group consisting of a crude extract, blood, semen, saliva, urine, mucus, stool, sputum, protein mixture and any other biological sample.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule, wherein the biomolecule is selected from the / group consisting of amino acids, peptides and nucleic acid.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the biomolecule is selected from the group consisting of peptides, polypeptides, proteins, fusion proteins, single stranded RNA, double stranded RNA, single stranded DNA and double stranded DNA.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the biomolecule is a double stranded D A.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostaicture to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule, wherein the light is a visible light or ultraviolet radiation or infrared radiation.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material-biomolecule complex; and exposing the nanostructure-linker-photolytic material-biomolecule complex to light to isolate the biomolecule, wherein the light is a visible light.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-linker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the light is an ultraviolet radiation.
  • a method for isolation of biomolecules from a sample comprises functionalizing a nanostructure to obtain a functionalized nanostructure; attaching a linker to the functionalized nanostructure; linking a photolytic material to the linker; contacting a sample having biomolecules to obtain a nanostructure-linker-photolytic material- biomolecule complex; and exposing the nanostructure-Iinker-photolytic material- biomolecule complex to light to isolate the biomolecule, wherein the light is an infrared radiation.
  • a method for detecting and/or isolating a biomolecule of interest in a sample comprises contacting a sample comprising a biomolecule with a composite comprising a nanostructure attached with a photolytic material via a linker; detecting presence of composite-biomolecule complex formed, and isolating - biomolecule from said composite-biomolecule complex.
  • the nanostructure as disclosed in the present invention is selected from a group consisting of nanocages, nanocrystallites, nanobelts, nanoneedles, nanocomposites, nanofabrics, nanofibers, nanoflakes, nanoflowers, nanofoams, nanomeshes, nanoparticles, nanopillars, nanopin films, nanorings, nanorods, nanoshells, nanopowders, nanoclusters, nanowires, nanotubes, quantum dots, quantum heterostructures.
  • the nanostructure as disclosed in the present invention is selected from a group consisting of carbon-based nanostructure, metal-based nanostructure, metal oxide-based nanostructure and silica based nanostructure.
  • the carbon-based nanostructure as disclosed in the present invention is selected from a group consisting of carbon nanotubes, a single-walled carbon nanotubes, multi-walled carbon nanotubes and fullerenes.
  • the metal-based nanostructure as disclosed in the present invention is selected from a group consisting of gold, silver, nickel, platinum nanoparticles.
  • the metal oxide-based nanostructure as disclosed in the present invention is Zinc oxide nanostructure or Titanium dioxide or Iron oxide nanostructure.
  • the biomolecule is selected from a group consisting of nucleic acid, DNA, RNA, SNP, cell marker proteins, cellular toxins, polypeptide, peptide, amino acid, protein, fusion protein, antibody, antibody fragment, small molecules, lipids and RNA or DNA virus.
  • the sample is selected from a group consisting of crude extract, blood, semen, tears, saliva, urine, mucus, stool, sputum, phlegm, and protein mixture, sweat, urine, plasma, lymph, spinal fluid, cells, microorganisms, a combination thereof, and aqueous dilutions thereof.
  • a composition for detecting and/or isolating a biomolecule of interest in a sample wherein the composition comprises a plurality of nanostructures attached with a photolytic material via a linker.
  • a device for detecting and/or isolating a biomolecule of interest in a sample comprising a plurality of nanostructures attached with a photolytic material via a linker, a support and a substrate.
  • the nanomaterial based composition as disclosed in the present invention can be used for biodiagnostic screening of proteins and nucleic acids and other relevant biomolecules. Further, nanostructured materials as disclosed in the present invention exhibits a unique electronic and photonic properties with biomaterials.
  • the nanorods of the present invention are used for controlling electrical and catalyst effect of different biomolecule samples and isolation of intracellular membranes from a given sample.
  • ' .he nanomaterial based composition as disclosed in the present invention shows synergetic properties for binding antigen, antibody or DNA and exhibits increased binding strength and immobilizes the targeted DNA, protein or small biomolecules.
  • the principles and practice of the invention may contribute, in due course, to the development of sensors and to using nanoscale devices for in-vivo applications directed toward cellular physiology, medical screening, and diagnosis.
  • Sensor devices based on the nanostructure composition as disclosed in the present invention may be constructed, according to the principles of the invention.
  • a novel method was developed based upon pressure assisted hydrothermal grovvlh of tunable ZnO single crystal nanorods structures.
  • the pressure on nucleation site was defined by the height of the water column. Dimensions of the growing features such as length, diameter, and cluster size were optimized by a fine tuning of pressure over the nucleation site. The morphology and dimensions of the ZnO nanorods were measured and analysed.
  • Hydrothermal method is a technique to grow single crystals in high temperature and high vapor pressure solution. Hydrothermal reaction takes place during the heating and cooling span and during this duration particle nucleates and grows. This method facilitates the dissolution of almost all inorganic substances in water at high temperatures and pressures. The dissolved material subsequently crystallizes from the fluid. The reaction was carried out in a Teflon bottle by external heating in a furnace, the bottle worked as a hydrothermal chamber.
  • Step 1 Zinc substrates of dimensions 10 mm x 10 mm x 0.25mm were taken.
  • Step 2 Zinc foil was first cleaned by ultrasonication in acetone for 5 minutes followed by wash with distilled water to make the surface free from dust and oxide particles and any other surface adsorbents before loading for the growth process.
  • Step 4 Each foil was then placed at the centre of the base inside the hydrothermal chambers.
  • Step 5 Volume was filled up to a level in the chamber thereby producing a liquid column which exerts pressure at the base.
  • the pressure on the base was correlated to liquid volume and the volume of the air column.
  • Step 6 The hydrothermal chamber was sealed with airtight screw cap and the setup was heated at 100°C for 14 hrs.
  • Nanorods of length scale 200 to 300 nm and diameter up to 90 nm was grown by the above mentioned process.
  • zinc oxide crystallizes in hexagonal form which corresponds to space group C6mc.
  • This structure consists of planes that arc composed of tetrahedrally coordinated 0 2 ⁇ and Zn 2+ ions.
  • the basal plane is the most common polar plane.
  • Fig.3 represents the typical growth shape of ID hexagonal shaped ZnO nanorod. Planar defects and twins have been found to occur parallel to the (0001 ) plane, however, dislocations are rarely observed in this crystal.
  • Zinc oxide exhibits piezoelectric properties due its unique structure.
  • the origin of piezoelectric characteristic is because of crystalline structure in which the oxygen atoms and zinc atoms are tetrahedrally bonded.
  • the hydrothennal technique was followed to synthesize nanorods of ZnO.
  • the preliminary characterization of ZnO nanorods were based upon the Scanning Electron Microscopy (SEM) (Zeiss Ultra55) images.
  • SEM Scanning Electron Microscopy
  • the presence of crystalline phases was determined from XRD pattern for nanorods array film prepared with distilled H 2 0 and 0.6M H 2 0 2 in 30 ml of the solution.
  • Table 1 summarizes the SEM properties of the nanorods grown at various pressures in different solutions. Nanorods of length scale 200 to 300 nm and diameter up to 90 nm have been grown by the above mentioned hydrothermal scheme. Reaction enthalpy at the Zn substrate surface is expected to increase in (South Pole) direction along with an increment in hydrostatic pressure.
  • Table 1 The dimensional features of nanorods grown at various concentrations
  • Example 2 2 mg of ZnO nanorods as described in Example 1 was taken in powder form and 2 mM of 16-(2-pyridyl dithiol) hexadecanoic acid (PDHA), 4 mM of N-(15-carboxy pentadecanoyloxy) succinimide (NHS) was added to it. 10 mM phosphate buffer was added to above mixture to make up the volume to 1 ml. Above mixture was stirred at 300 rpm for 2 hours at room temperature 2 hours. The mixture was then washed with deionized water thoroughly by centrifugation at 5000rpm for 5 minutes and dried.
  • PDHA 16-(2-pyridyl dithiol) hexadecanoic acid
  • NHS N-(15-carboxy pentadecanoyloxy) succinimide
  • Step 1 2 mg of ZnO nanorods in powder form of Example 1
  • Step 2 2mM of bifunctional carboxylic acid 16-(2-pyridyldithiol) hexadecanoic acid (PDHA) dissolved in 2: 1 butanol: ethanol.
  • Step 4 l OmM phosphate buffer was added to above mixture to make up the volume to 1 ml.
  • Step 5 Above mixture was stirred at 300 rpm for 2 hours at room temperature.
  • Step 6 The above mix was washed thrice with deionized water by centrifugation at 5000 rpm for 5 minutes.
  • Step 7 The washed sample was dried at room temperature and functional ized Zn (f- ZnO) nanorod was collected.
  • Step 8 Characterization of f-ZnO was done UV-Vis and FT-IR spectroscopy Charcterization ZnO functionalization was done by UV spectroscopy. As represented in Fig.8 increasing concentration of ZnO gives a linear yield in functionalized ZnO nanorods by the above optimized process. With a saturated concentration of 2mg/ml ZnO nanorods, functionalization time was optimized and Fig.9 clearly presents that incubation time span of 2 hours results in high yield of functionalized ZnO nanorods.
  • Linker attachment on the f-ZnO nanorods 2 mg of f-ZnO nanorods prepared by the process as described above were added to 50 mM of N-( l 5-carboxy pentadecanoyloxy) succinimide (NHS) and 50 mM of 2-(N- morpholine)-ethane sulfonic acid (MES) in 10 ml deionized water. 50 mM of l -ethyl-3- (3-dimethylaminopropyl) (EDC) was added to above suspension and the mixture was stirred for up to 6 hours at room temperature. The mixture was thoroughly washed with deionized wa * er by centrifugation at 5000 for 5minutes and thereafter dried to collect ZnO-EDC.
  • NHS N-( l 5-carboxy pentadecanoyloxy) succinimide
  • MES 2-(N- morpholine)-ethane sulfonic acid
  • EDC l
  • Step 1 2mg of f-ZnO nanorods of Example 3
  • Step 2 50mM of N-hydroxysuccinimide (NHS) buffer and 50mM of 2-(N-morpholino) ethanesulfonic acid (MES) buffer in 10ml distill water.
  • NHS N-hydroxysuccinimide
  • MES 2-(N-morpholino) ethanesulfonic acid
  • Step 3 50mM of l -ethyl-3- 3-dimethylaminopropyl carbodiimide (EDC) was added to the above mix followed by stirring at 300 rpm for 6 hours at room temperature.
  • EDC l -ethyl-3- 3-dimethylaminopropyl carbodiimide
  • Step 4 The above mix was washed thrice with deionized water by centrifugation at 5000 rpm for 5 minutes.
  • Step 5 The washed sample was dried at room temperature and f-ZnO-EDC was collected.
  • ZnO-EDC collected from above step was added to a solution containing 50 mM of N- (15-carboxy pentadecanoyloxy) succinimide (NHS) and 50 mM of (2-(N-morpholine)- ethane sulfonic acid (MES) in 10ml deionized water. 2 mg of photolytic material Protoporphyrin (PPP) was added to the above solution and the entire mixture was dissolved in 3 ml of Methanol. The mixture was stirred for up to 6 hours in absence of light at room temperature and thereafter the mixture was washed with deionized water to collect ZnO-EDC-PPP.
  • NHS N- (15-carboxy pentadecanoyloxy) succinimide
  • MES (2-(N-morpholine)- ethane sulfonic acid
  • Step 2 2 mg of a photolytic material Protoporphyrin IX (PPP) in 3 ml of methanol.
  • Step 3 50mM of NHS buffer and 50mM of MES buffer in 10ml distill water.
  • Step 4 Above suspension was stirred for up to 6 hours in absence of light at 300 rpm under room temperature.
  • Step 5 The above mix was washed with deionized water by centrifugation at 5000 rpm for 5 minutes.
  • Step 6 ZnO-EDC-PPP was collected and the complex formation was confirmed by UV Vis as well as FT-IR spectroscopy
  • ZnO-EDC-PPP as prepared in Example 5 was added in 50 mM of NHS and 50 mM of (2-(N-morpholine)-ethane sulfonic acid (MES) in 10ml of deionized water. DNA binding to above complex was checked with different concentration of DNA ranging from 0.2-2 ⁇ . The extent of binding was checked over a time span of 1 to 5 minute, and the binding was confirmed by UV spectroscopy.
  • Fig.6. represents the schematic diagram of ZnO-EDC-PPP-DNA complex, where in A represents Zinc Oxide (ZnO), B represents l-ethyl-3-(3-dimethylaminopropyl) (EDC), C represents Protoporphyrin (PPP) and D represents DNA.
  • Step 1 ZnO-EDC-PPP of Example 5 was added in 50 mM of NHS and 50 mM of MES buffer in 10ml of DI water.
  • Step 2 0.2-2 ⁇ DNA was added to above mixture (Step 20) and incubated for upto 5 minutes.
  • Step 3 At regular time intervals, DNA binding was analyzed by UV spectrophotometry and FTIR spectroscopy
  • Step 4 The suspension having DNA bound to PPP was exposed to LED (goo650nm wavelength) for up to 2 min.
  • Step 5 The cleavage was checked under different intensities and for different time of exposure.
  • Step 6 DNA cleavage was analyzed by UV spectrophotometry
  • DNA binding and photocleavage was analyzed by UV spectrophotometry.
  • DNA binding to ZnO-EDC-PPP leads to a complex structure formation which results an increase in UV absorbance at 260nm as compared to the same concentration of free DNA added to buffer.
  • 0.2 ⁇ no binding was observed inspite of incubation till 4 minutes [Fig 13(a)j.As the DNA concentration was increased the time required for complex formation increases as observed in case of 1 2 ⁇ DNA [Fig 13(d) and Fig 13(e)].
  • the photocleavgae was indicated by the drastic drop in UV absorbance which was similar to the absorbance yielded by free DNA in buffer.
  • Post cleavage UV absorbance was measured post incubation of samples for 5 minutes at room temperature so as to prevent chances of reannealing and confirm complete cleavage.
  • the UV spectrophotometric and FT-IR analyses also indicate a selective binding of the biomolecule, i.e. binding of DNA to the functionalized nanorod with photo-linker.
  • the attachment of the DNA probe to the PPP leads to an increase in the UV absorbance as compared to either the unbound PPP or the free DNA in the buffer (Fig.13).
  • the selective binding of the nanorod-biomolecule is also reflected by the concentration dependent factor of biomolecule for optimal binding.
  • an optimal concentration of biomolecule for example, at concentration above 1 ⁇ , was required for the complex formation.
  • the step-wise functionalization followed by subsequent binding of the photolinker and specific biomolecule was also confirmed by FT-IR analysis (step 1 -3 of Fig.12.).
  • the present technique of nanorod based screening of biomolecules holds the advantage of being a simple and efficient and fast process of functionalization and biomolecule binding.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention concerne un procédé et une composition permettant de détecter et/ou d'isoler une biomolécule d'intérêt dans un échantillon, ladite composition comprenant une pluralité de nanostructures liées à un matériau photolytique par l'intermédiaire d'un lieur. Le procédé décrit n'a pas d'effet destructeur sur la biomolécule. Un dispositif comprenant une pluralité de nanostructures liées à un matériau photolytique par l'intermédiaire d'un lieur selon la présente invention, un support et un substrat est également décrit.
PCT/IB2012/002200 2011-11-01 2012-11-01 Procédé de détection et/ou d'isolement d'une biomolécule faisant appel à des nanostructures Ceased WO2013064885A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3751CH2011 2011-11-01
IN3751/CHE/2011 2011-11-01

Publications (1)

Publication Number Publication Date
WO2013064885A1 true WO2013064885A1 (fr) 2013-05-10

Family

ID=47222153

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/002200 Ceased WO2013064885A1 (fr) 2011-11-01 2012-11-01 Procédé de détection et/ou d'isolement d'une biomolécule faisant appel à des nanostructures

Country Status (1)

Country Link
WO (1) WO2013064885A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103913443A (zh) * 2014-04-23 2014-07-09 安徽师范大学 一种基于DNA-银纳米簇（DNA-Ag NCs）适体传感器，及其制备方法，用途以及检测方法
CN105002161A (zh) * 2015-07-28 2015-10-28 福建师范大学 基于磁珠法快速提取动物粪便微生物基因组的方法
CN105348291A (zh) * 2015-09-25 2016-02-24 江苏大学 锡卟啉轴向共价功能化多壁碳纳米管非线性光学材料及其制备方法
WO2016184062A1 (fr) * 2015-05-15 2016-11-24 南通明芯微电子有限公司 Biocapteur basé sur un nanomatériau semi-conducteur sensible de manière photoélectrique
CN107759803A (zh) * 2017-11-13 2018-03-06 山东师范大学 一种四巯基卟啉化合物及其制备方法和用途
CN108459159A (zh) * 2018-02-11 2018-08-28 莎穆(上海)生物科技有限公司 超分子自组装介导网状纳米金增强免疫层析试纸条灵敏度的新方法
CN111474336A (zh) * 2020-03-21 2020-07-31 南昌大学 一种铁氰化镍纳米粒化学发光适体传感器的制备方法及基于其检测8-OhdG的方法
CN111825684A (zh) * 2020-03-12 2020-10-27 同济大学 可修饰型超共轭三重熔融卟啉二聚体强双光子吸收材料及其制备
CN112094277A (zh) * 2020-03-12 2020-12-18 同济大学 三重熔融卟啉二聚体共价功能化单壁碳纳米管非线性纳米杂化材料及其制备

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132070A1 (en) 2002-01-16 2004-07-08 Nanomix, Inc. Nonotube-based electronic detection of biological molecules
US20080057489A1 (en) * 2006-08-07 2008-03-06 Chi Sung-Min Photolabile Compound and Substrate for Oligomer Probe Array with the Same
WO2011044671A1 (fr) * 2009-10-16 2011-04-21 University Health Network Nanovésicules de porphyrine
US20110257033A1 (en) 2010-04-19 2011-10-20 Strano Michael S Polymer-nanostructure composition for selective molecular recognition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132070A1 (en) 2002-01-16 2004-07-08 Nanomix, Inc. Nonotube-based electronic detection of biological molecules
US20080057489A1 (en) * 2006-08-07 2008-03-06 Chi Sung-Min Photolabile Compound and Substrate for Oligomer Probe Array with the Same
WO2011044671A1 (fr) * 2009-10-16 2011-04-21 University Health Network Nanovésicules de porphyrine
US20110257033A1 (en) 2010-04-19 2011-10-20 Strano Michael S Polymer-nanostructure composition for selective molecular recognition

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"Fine particles: Synthesis, characterization, and mechanisms of growth", vol. 92, 2000, DEKKER
ALEXANDER, RENEE R.; JOAN M. GRIFFITHS: "Basic Biochemical Methods", 1993, WILEY-LISS
BOLLAG, DANIEL M.; STUART J. EDELSTEIN: "Protein Methods", 1991, WILEY-LISS
C. BURDA; X. CHEN; R. NARAYANAN; M.A. EI-SAYED: "Chemistry and properties of nanocrystals of different shapes", CHEM. REV., vol. 105, 2005, pages 1025
C. YANG; H. SHEU; K. CHAO: "Templated synthesis and structural study of densely packed metal nanostructures in mcm-41 and mcm-48", ADV. FUNCT. MATER, vol. 12, 2002, pages 143
D. K. YI; S. S. LEE; J. Y. YING: "Synthesis and applications of magnetic nanocomposite catalysts", CHEM. MATER., vol. 18, 2006, pages 2459
EUGENII KATZ; ITAMAR WILLNER, ANGEW. CHEM. INT. ED., vol. 43, 2004, pages 6042 - 6108
LU, J; PAN, W.; HE, R.; JIN, J.; LIAO, X.; WU, B.; ZHAO, P.; GUO, H.: "DNA-binding and photocleavage studies of metallofluorescein porphyrin complexes of zinc(II) and copper(II", TRANSITION MET CHEM, vol. 37, 2012, pages 497 - 503, XP035081325, DOI: doi:10.1007/s11243-012-9615-2
M. S. FLEMING; D. R. WALT: "Stability and exchange studies of alkanethiol monolayers on gold-nanoparticle-coated silica microspheres", LANGMUIR, vol. 17, 2001, pages 4836
MEZO, G.; HERENYI, L.; HABDAS, J.; MAJER, Z.; KURDZIEL, BM.; TÓTH, K.; CSIK, G: "Syntheses and DNA binding of new cationic porphyrin-tetrapeptide conjugates", BIOPHYSICAL CHEMISTRY, vol. 155, 2011, pages 36 - 44, XP028371777, DOI: doi:10.1016/j.bpc.2011.02.007
NATHANIEL L. ROSI; CHAD A. MIRKIN, DEPARTMENT OF CHEMISTRY, NORTHWESTERN UNIVERSITY, vol. 105, 2005, pages 1547 - 1562
Q. A. PANKHURST; J. CONNOLLY; S. K. JONES; J. DOBSON: "Applications of magnetic nanoparticles in biomedicine", J. PHYS. D: APPL. PHYS., vol. 36, 2003, pages R167, XP002420505, DOI: doi:10.1088/0022-3727/36/13/201
RAPHAEL NIEPELT; ULRICH C SCHRODER; JANA SOMMERFELD; IRMA SLOWIK; BETTINA RUDOLPH; ROBERT MILLER; BARBARA SEISE; ANDREA CSAKI; WOL: "Biofunctionalization of zinc oxide nanowires for DNA sensory applications", NANOSCALE RESEARCH LETTERS, vol. 6, 2011, pages 511
S. SUN; C.B. MURRAY: "Synthesis of monodisperse cobalt nanocrystals and their assembly intomagnetic superlattices", J. APPL. PHYS., vol. 85, 1999, pages 4325
SCOPES, ROBERT K: "Protein Purification: Principles and Practice", 1994, SPRINGER VERLAG
TARATULA. 0.; GALOPPINI. E.; MENDELSOHN, R.: "Stepwise Functionalization of ZnO Nanotips with DNA", LANGMUIR, vol. 25, 2009, pages 2107 - 2113
XIE, Y.; HE, Y.; IRWIN, PL.; JIN, T.; SHI, T.: "Antibacterial Activity and Mechanism of Action of Zinc Oxide Nanoparticles against Campylobacter jejuni", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 77, no. 7, 2011, pages 2325 - 2331

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103913443A (zh) * 2014-04-23 2014-07-09 安徽师范大学 一种基于DNA-银纳米簇（DNA-Ag NCs）适体传感器，及其制备方法，用途以及检测方法
CN103913443B (zh) * 2014-04-23 2016-09-14 安徽师范大学 一种基于DNA-银纳米簇(DNA-Ag NCs)适体传感器的用途以及检测方法
WO2016184062A1 (fr) * 2015-05-15 2016-11-24 南通明芯微电子有限公司 Biocapteur basé sur un nanomatériau semi-conducteur sensible de manière photoélectrique
CN105002161A (zh) * 2015-07-28 2015-10-28 福建师范大学 基于磁珠法快速提取动物粪便微生物基因组的方法
CN105348291A (zh) * 2015-09-25 2016-02-24 江苏大学 锡卟啉轴向共价功能化多壁碳纳米管非线性光学材料及其制备方法
CN107759803A (zh) * 2017-11-13 2018-03-06 山东师范大学 一种四巯基卟啉化合物及其制备方法和用途
CN108459159A (zh) * 2018-02-11 2018-08-28 莎穆(上海)生物科技有限公司 超分子自组装介导网状纳米金增强免疫层析试纸条灵敏度的新方法
CN111825684A (zh) * 2020-03-12 2020-10-27 同济大学 可修饰型超共轭三重熔融卟啉二聚体强双光子吸收材料及其制备
CN112094277A (zh) * 2020-03-12 2020-12-18 同济大学 三重熔融卟啉二聚体共价功能化单壁碳纳米管非线性纳米杂化材料及其制备
CN112094277B (zh) * 2020-03-12 2021-10-08 同济大学 三重熔融卟啉二聚体共价功能化单壁碳纳米管非线性纳米杂化材料及其制备
CN111825684B (zh) * 2020-03-12 2021-10-08 同济大学 可修饰型超共轭三重熔融卟啉二聚体强双光子吸收材料及其制备
CN111474336A (zh) * 2020-03-21 2020-07-31 南昌大学 一种铁氰化镍纳米粒化学发光适体传感器的制备方法及基于其检测8-OhdG的方法

Similar Documents

Publication Publication Date Title
WO2013064885A1 (fr) Procédé de détection et/ou d'isolement d'une biomolécule faisant appel à des nanostructures
Barbosa et al. Current nanotechnology advances in diagnostic biosensors
Malekzad et al. Noble metal nanoparticles in biosensors: recent studies and applications
Pandit et al. Nanotechnology based biosensors and its application
Asefa et al. Recent advances in nanostructured chemosensors and biosensors
Wang et al. Bottom-up synthesis and sensor applications of biomimetic nanostructures
Ju et al. NanoBiosensing: principles, development and application
Chauhan et al. Chitosan-based biosensors-A comprehensive Review
Yeom et al. Nanostructures in biosensor-a review
Zheng et al. Electrochemical aptasensor of carcinoembryonic antigen based on concanavalin a-functionalized magnetic copper silicate carbon microtubes and gold-nanocluster-assisted signal amplification
Li et al. Electrochemical and optical biosensors based on nanomaterials and nanostructures: a review
Goswami et al. Nanotechnology-based biosensors for biomedical applications
Jian et al. Introducing graphitic carbon nitride nanosheets as supersandwich-type assembly on porous electrode for ultrasensitive electrochemiluminescence immunosensing
Takahashi et al. Oxide nanowire microfluidics addressing previously-unattainable analytical methods for biomolecules towards liquid biopsy
Mayegowda et al. Heavy metal detection by nanotechnology-based sensors
Bertoncello Nanomaterials for biosensing with electrochemiluminescence (ECL) detection
Li et al. A high-performance SERS imprinted membrane based on Ag/CNTs for selective detection of spiramycin
Attaallah et al. Nanobiosensors for bioclinical applications: pros and cons
Vojoudi et al. Bio‐Functionalized MXenes: Synthesis and Versatile Applications
Anusha et al. Nanomaterials in electrochemical biosensors and their applications
KR101488436B1 (ko) 금 나노입자를 이용한 ｄｎａ 혼성화 반응의 단일 부정합 검출방법
Ramezani Farani et al. Biomimetic Carbon‐Based Nanomaterials: From Design Strategies to Next‐Generation Biosensing and Theranostic Applications
Singh et al. Approaches to produce hybrid nanomaterials for engineering applications
WO2019102482A1 (fr) Nanopores modifiés par des acides aminés et leurs utilisations
Zheng et al. Current progress in the development of biosensors based on nanomaterials for the detection of inorganic arsenic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12790955

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12790955

Country of ref document: EP

Kind code of ref document: A1